Myrsini Gianatsi: “Reducing the time patients spend on ineffective treatments can have a real impact on their quality of life”
Edgar Angelats: “Many patients with IMIDs do not respond to current therapies and need better solutions”
Stefania Madonna: “DocTIS represents a shift from treating the average patient to treating the individual”
Adrià Aterido: “Translating research into better patient care is like nurturing a plant: slow and patient, but rewarding upon reaching the clinic”
Sergio Martínez: “Combining existing drugs could impact clinical practice much faster than developing new therapies”
Nerea Clemente: “Working in DocTIS has shown me how complex it is to move from research to clinical application”
